Quarterly Results • Search Archive

Panacea Biotec Limited
Results, Financials & Updates

Follow Panacea Biotec Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Panacea Biotec Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: PANACEABIO
Revenue from operations₹199.57 CrReported in the latest covered quarter
Profit after tax₹2.20 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Panacea Biotec Limited is an innovation-led biotechnology and pharmaceutical company engaged in research, development, manufacture and marketing of vaccines and pharmaceutical formulations. The company's primary operational focus is centered around two major segments: Vaccines and Formulations, serving both institutional customers and commercial markets.

← All quarterly results

Quarter history

Panacea Biotec Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹199.57 Cr · PAT ₹2.20 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.